Clinical research investigates mechanisms of human disease, interventions, or new technologies, but pregnant women are often excluded from clinical studies. Few studies, beyond research on pregnancy, are designed to address questions relevant to pregnant women. A recent National Institutes of Health workshop considered the barriers and opportunities in conducting clinical research studies enrolling pregnant women.
Get full access to this article
View all access options for this article.
References
1.
BaylisF. Pregnant women deserve better. Nature, 2010; 465:689–690.
2.
MacklinR. Enrolling pregnant women in clinical research. Lancet, 2010; 375:632.
3.
FadenR, LyerlyAD, LittleMO. A custom drug. New York Times, May10, 2009.
4.
RochmanB. Women's health: Pregnancy and pills. Time, June8, 2009.
5.
LyerlyAD, LittleMO, FadenR. Int J Fem Approaches Bioethics, 2008; 1:5–22.
6.
Second Wave Initiative. kennedyinstitute.georgetown.edu/secondwave/. 2011 June 27.
7.
LagakosSW, GableAR. Methodological challenges in biomedical HIV prevention trials. Washington, DC: National Academies Press, 2008.
8.
MastroianniAC, FadenR, FedermanD. Women and health research: Ethical and legal issues relating to the inclusion of women in clinical research. Washington, DC: National Academies Press, 1994.
9.
KristofND. At risk from the womb. New York Times, October2, 2010.
10.
ChambersCD, PolifkaJA, FriedmanJM. Drug safety in pregnant women and their babies: Ignorance is not bliss. Clin Pharmacol Ther, 2008; 83:181–183.
11.
AndradeSE, GurwitzJH, DavisRLet al.Prescription drug use in pregnancy. Am J Obstet Gynecol, 2004; 191:398–407.
12.
LacroixI, Damase-MichelC, LaperyreMet al.Prescription of drugs during pregnancy in France. Lancet, 2000; 356:1735–1736.
13.
De ViganC, De WalleHE, CordierSet al.Therapeutic drug use during pregnancy: A comparison in four European countries. OECM Working Group. Occupational Exposure and Congential Anomalies. J Clin Epidemiol, 1999; 52:977–982.
14.
Food and Drug Administration. Guidance for industry: Pharmacokinetics in pregnancy 2004. www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072133.pdf. 2011 June 27.
15.
International Conference on Harmonisation E2E. Pharmacovigilance Planning. www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2E/Step4/E2E_Guideline.pdf. 2011 June 27.
16.
Food and Drug Administration. Health organizations to study safety of medications taken during pregnancy. FDA News Release, December30, 2009. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ucm195934.htm. 2011 June 27.
17.
GoldkindSF, SahinL, GallauresiB. Enrolling pregnant women in research—Lessons from the H1N1 influenza pandemic. N Engl J Med, 2010; 362:2241–2243.
18.
U.S. Code of Federal Regulations 45 CFR 46. Protection of human subjects. www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html#subpartb. 2011 June 27.
19.
Council for International Organizations of Medical Sciences (CIOMS). International ethical guidelines for biomedical research involving human subjects. The World Health Organization, 2002. www.cioms.ch/publications/guidelines/guidelines_nov_2002_blurb.htm. 2011 June 27.
20.
H1N1 vaccine in pregnant women. clinicaltrials.gov/ct2/show/NCT00963430. 2011 June 27.
21.
Novartis H1N1 vaccine in pregnant women. clinicaltrials.gov/ct2/show/NCT00992719. 2011 June 27.
22.
NyuntM, AdamI, KayentaoKet al.Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy. Clin Pharmacol Ther, 2010; 87:226–234.
23.
BeigiR, NoguchiL, MacioIet al.Maternal single-dose pharmacokinetics and placental transfer of Tenofovir 1% vaginal gel among health term gravidas. 2010 International Microbicides Conference (M2010)www.microbicides2010.org/files/pregnancy%20Beigi%20abstract.pdf. 2011 June 27.
24.
JonesH, KaltenbachK, HeilSHet al.Neonatal abstinence syndrome after methodone or buprenorphine exposure. N Engl J Med, 2010; 363:2320–2331.
25.
YonkersKA. The treatment of women suffering from depression who are either pregnant or breastfeeding. Am J Psychiatry, 2007; 164:1457–1458.
26.
The HAPO Study Cooperative Research Group. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Int J Gynecol Obstet, 2002; 78:69–77.
27.
CardonickE, UsmaniA, GhaffarS. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy. Results of an international registry. Am J Clin Oncol, 2010; 33:221–228.
